1. Home
  2. DRCT vs HBIO Comparison

DRCT vs HBIO Comparison

Compare DRCT & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRCT
  • HBIO
  • Stock Information
  • Founded
  • DRCT 2018
  • HBIO 1901
  • Country
  • DRCT United States
  • HBIO United States
  • Employees
  • DRCT N/A
  • HBIO N/A
  • Industry
  • DRCT Computer Software: Programming Data Processing
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • DRCT Technology
  • HBIO Industrials
  • Exchange
  • DRCT Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • DRCT 16.7M
  • HBIO 19.6M
  • IPO Year
  • DRCT 2022
  • HBIO 2000
  • Fundamental
  • Price
  • DRCT $0.59
  • HBIO $0.44
  • Analyst Decision
  • DRCT Strong Buy
  • HBIO Buy
  • Analyst Count
  • DRCT 1
  • HBIO 2
  • Target Price
  • DRCT $6.00
  • HBIO $3.00
  • AVG Volume (30 Days)
  • DRCT 151.3K
  • HBIO 1.1M
  • Earning Date
  • DRCT 05-06-2025
  • HBIO 08-07-2025
  • Dividend Yield
  • DRCT N/A
  • HBIO N/A
  • EPS Growth
  • DRCT N/A
  • HBIO N/A
  • EPS
  • DRCT N/A
  • HBIO N/A
  • Revenue
  • DRCT $48,170,000.00
  • HBIO $91,397,000.00
  • Revenue This Year
  • DRCT $50.71
  • HBIO N/A
  • Revenue Next Year
  • DRCT $26.31
  • HBIO $9.75
  • P/E Ratio
  • DRCT N/A
  • HBIO N/A
  • Revenue Growth
  • DRCT N/A
  • HBIO N/A
  • 52 Week Low
  • DRCT $0.44
  • HBIO $0.28
  • 52 Week High
  • DRCT $6.59
  • HBIO $3.60
  • Technical
  • Relative Strength Index (RSI)
  • DRCT 55.55
  • HBIO 49.18
  • Support Level
  • DRCT $0.56
  • HBIO $0.42
  • Resistance Level
  • DRCT $0.68
  • HBIO $0.48
  • Average True Range (ATR)
  • DRCT 0.04
  • HBIO 0.05
  • MACD
  • DRCT 0.01
  • HBIO -0.01
  • Stochastic Oscillator
  • DRCT 49.94
  • HBIO 24.69

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: